Study: WATCHMAN FLX LAA Closure Device Maintains Safety, Efficacy at 2 Years

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650 Annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

Study: WATCHMAN FLX LAA Closure Device Maintains Safety, Efficacy at 2 Years

Posted: 07/21/2021
Author:
Amer Aladin, CRTonline.org

The WATCHMAN FLX left atrial appendage (LAA) closure device maintained its safety and efficacy through 2 years after implantation in patients with nonvalvular atrial fibrillation (NVAF), according to late-breaking trial results presented Wednesday at Transcatheter Valve Therapies (TVT) 2021.

Most Viewed Pages

Clonal Hematopoiesis’ Influence on CV Mortality Opens Role as Risk-Stratifying Tool, Study Suggests

Tricuspid Annuloplasty Alongside Mitral Valve Repair Linked to Pacemaker Implantation, Subsequent Risk

Study Calls for Periprocedural MI Definition Review to ‘Improve Usefulness’

How should left ventricular function and other high-risk features influence selection of revascularization?

Ticagrelor Decreases Limb Risk in T2DM and Atherosclerosis Patients, Increases Bleeding Risk: THEMIS Trial

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

Study: WATCHMAN FLX LAA Closure Device Maintains Safety, Efficacy at 2 Years

Most Viewed Pages

Explore the Site

Stay Connected